Precision for Medicine, a global leader in biomarker-driven clinical research and development, has announced the opening of a new office in Singapore. This strategic expansion strengthens Precision's significant presence across the Asia-Pacific (APAC) region, serving as a crucial hub for enhanced client support and accelerated regional growth.
Singapore's central location and sophisticated infrastructure make it ideal for growing Precision's regional presence, including Mainland China, Hong Kong, India, South Korea, Taiwan and Australia.
Through its expanded footprint, embedded senior leaders and a dedicated team of over 500 employees, Precision underscores its commitment to navigating the complexities of regional drug development and commercialization.
